{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T08:43:21Z","timestamp":1771922601754,"version":"3.50.1"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to report a case of Vogt\u2013Koyanagi\u2013Harada (VKH) disease in a 53-year-old man with renal failure and diabetes, highlighting the challenges in diagnosing VKH amidst complex systemic comorbidities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A case report was conducted through a retrospective review of the patient\u2019s medical history, clinical presentations, diagnostic workup, and treatment course.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A 53-year-old man with renal failure, hypoalbuminemia, and diabetes presented with blurred vision. Initial findings included bilateral serous retinal detachment with subretinal septa, choroidal thickening, and left eye vitreous hemorrhage, without anterior chamber inflammation. Subsequent anterior segment inflammation and a positive response to combined corticosteroids and adalimumab confirmed VKH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case underscores the diagnostic complexity of VKH in patients with multiple systemic conditions. Corticosteroid management in such individuals requires meticulous attention, emphasizing the need for close monitoring of blood glucose and overall systemic status during treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1733153","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T07:01:22Z","timestamp":1768892482000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Co-occurrence of Vogt\u2013Koyanagi\u2013Harada disease, diabetic retinopathy, and advanced chronic kidney disease: a case report"],"prefix":"10.3389","volume":"13","author":[{"given":"Yutong","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Shijiazhuang People's Hospital","place":["Shijiazhuang, Hebei, China"]},{"name":"Graduate School, Hebei Medical University","place":["Shijiazhuang, Hebei, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Shijiazhuang People's Hospital","place":["Shijiazhuang, Hebei, China"]},{"name":"Graduate School, Hebei Medical University","place":["Shijiazhuang, Hebei, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Shijiazhuang People's Hospital","place":["Shijiazhuang, Hebei, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,20]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1136\/bjo.80.11.1002","article-title":"Melanoma specific Th1 cytotoxic T lymphocyte lines in Vogt-Koyanagi-Harada disease","volume":"80","author":"Norose","year":"1996","journal-title":"Br J Ophthalmol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s002510050375","article-title":"Tyrosinase epitope recognized by an HLA-DR-restricted T-cell line from a Vogt-Koyanagi-Harada disease patient","volume":"47","author":"Kobayashi","year":"1998","journal-title":"Immunogenetics"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12886-024-03410-z","article-title":"A case report: co-occurrence of probable Vogt-Koyanagi-Harada disease and diabetic retinopathy","volume":"24","author":"Li","year":"2024","journal-title":"BMC Ophthalmol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2147\/imcrj.s283565","article-title":"Bilateral exudative retinal detachment in a young patient with chronic renal failure","volume":"14","author":"Otuka","year":"2021","journal-title":"Int Med Case Rep J"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1159\/000543005","article-title":"Bilateral serous retinal detachment as an initial manifestation of systemic lupus erythematosus due to hypoalbuminemia: a case report","volume":"16","author":"Xu","year":"2024","journal-title":"Case Rep Ophthalmol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1186\/s13256-023-04236-x","article-title":"Bilateral central serous retinal detachment in a patient with nephrotic syndrome: a case report","volume":"17","author":"Sadeghi","year":"2023","journal-title":"J Med Case Rep"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1070792","DOI":"10.3389\/fneph.2022.1070792","article-title":"Retinal detachments in a patient with minimal change nephrotic syndrome: case report and review of the literature","volume":"2","author":"Ye","year":"2023","journal-title":"Front Nephrol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3341\/kjo.2019.0035","article-title":"Bilateral central serous retinal detachment in protein-losing enteropathy","volume":"33","author":"Mafi","year":"2019","journal-title":"Korean J Ophthalmol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/0014-4835(71)90094-7","article-title":"Flow conductivity of retina and its role in retinal adhesion","volume":"12","author":"Fatt","year":"1971","journal-title":"Exp Eye Res"},{"key":"ref10","first-page":"1776","article-title":"Measurement of the volume flow and hydraulic conductivity across the isolated dog retinal pigment epithelium","volume":"28","author":"Tsuboi","year":"1987","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref11","first-page":"616","article-title":"Effects of subretinal and systemic osmolality on the rate of subretinal fluid resorption","volume":"25","author":"Negi","year":"1984","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/s0002-9394(02)01464-2","article-title":"Graft-vs-host-disease-associated conjunctival chemosis and central serous chorioretinopathy after bone marrow transplant","volume":"134","author":"Cheng","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.4103\/ijo.ijo_1944_21","article-title":"Role of swept source optical coherence tomography in management of acute Vogt-Koyanagi-Harada\u2019s disease","volume":"70","author":"Ganesh","year":"2022","journal-title":"Indian J Ophthalmol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"Doc06","DOI":"10.3205\/oc000179","article-title":"Role of optical coherence tomography angiography in Vogt-Koyanagi-Harada disease","volume":"11","author":"Erba","year":"2021","journal-title":"GMS Ophthalmol Cases"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"772439","DOI":"10.3389\/fmed.2021.772439","article-title":"Optical coherence tomographic features and prognostic values of macular edema in Vogt-Koyanagi-Harada disease","volume":"8","author":"Qin","year":"2022","journal-title":"Front Med"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"3395","DOI":"10.1007\/s00417-021-05238-5","article-title":"Decrease of choriocapillary vascular density measured by optical coherence tomography angiography in Vogt-Koyanagi-Harada disease","volume":"259","author":"Liang","year":"2021","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.3390\/jcm12041630","article-title":"Past, present and (foreseeable) future of biological anti-TNF alpha therapy","volume":"12","author":"Leone","year":"2023","journal-title":"J Clin Med"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/312724a0","article-title":"Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin","volume":"312","author":"Pennica","year":"1984","journal-title":"Nature"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.3390\/ijms19082244","article-title":"Anti-TNF therapy in Crohn\u2019s disease","volume":"19","author":"Adegbola","year":"2018","journal-title":"Int J Mol Sci"},{"key":"ref20","first-page":"171","article-title":"The role of anti-TNF therapy in ulcerative colitis","volume":"67","author":"Cukovi\u0107-Cavka","year":"2013","journal-title":"Acta Med Croatica"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"799427","DOI":"10.3389\/fmed.2021.799427","article-title":"Adalimumab in Vogt-Koyanagi-Harada disease refractory to conventional therapy","volume":"8","author":"Yang","year":"2022","journal-title":"Front Med"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12348-023-00333-6","article-title":"Immunosuppressive therapy for Vogt-Koyanagi-Harada disease: a retrospective study and review of literature","volume":"13","author":"Rahman","year":"2023","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"3768","DOI":"10.1038\/s41467-023-39483-5","article-title":"A randomized non-inferiority trial of therapeutic strategy with immunosuppressants versus biologics for Vogt-Koyanagi-Harada disease","volume":"14","author":"Zhong","year":"2023","journal-title":"Nat Commun"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"380","DOI":"10.4103\/sjopt.sjopt_204_22","article-title":"Adalimumab treatment for chronic recurrent Vogt-Koyanagi-Harada disease with sunset glow fundus: a multicenter study","volume":"36","author":"Takeuchi","year":"2022","journal-title":"Saudi J Ophthalmol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"699","DOI":"10.21037\/atm-22-2668","article-title":"Systemic glucocorticoid-free therapy with adalimumab plus immunosuppressants versus conventional therapy in treatment-na\u00efve Vogt-Koyanagi-Harada disease patients","volume":"10","author":"Yang","year":"2022","journal-title":"Ann Transl Med"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s12886-024-03511-9","article-title":"Predictive factors and adalimumab efficacy in managing chronic recurrence Vogt-Koyanagi-Harada disease","volume":"24","author":"Feng","year":"2024","journal-title":"BMC Ophthalmol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1080\/09273948.2024.2346814","article-title":"Clinical and transcriptional profiles reveal the treatment effect of adalimumab in patients with initial-onset and recurrent Vogt-Koyanagi-Harada disease","volume":"33","author":"Guo","year":"2024","journal-title":"Ocul Immunol Inflamm"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"e0176157","DOI":"10.1371\/journal.pone.0176157","article-title":"The change of serum tumor necrosis factor alpha in patients with type 1 diabetes mellitus: a systematic review and meta-analysis","volume":"12","author":"Qiao","year":"2017","journal-title":"PLoS One"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/s12035-016-9702-z","article-title":"Association between tumor necrosis factor-\u03b1 and diabetic peripheral neuropathy in patients with type 2 diabetes: a meta-analysis","volume":"54","author":"Mu","year":"2016","journal-title":"Mol Neurobiol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1007\/s40123-022-00493-z","article-title":"Long-term safety and effectiveness of adalimumab in Japanese patients with noninfectious intermediate, posterior, or Panuveitis: post-marketing surveillance of 251 patients","volume":"11","author":"Namba","year":"2022","journal-title":"Ophthalmol Ther"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.4103\/ijo.ijo_3223_23","article-title":"Efficacy of adalimumab in noninfectious pediatric uveitis: analysis of 29 eyes from a tertiary eye care center in India","volume":"72","author":"Khan","year":"2024","journal-title":"Indian J Ophthalmol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1733153\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T07:38:20Z","timestamp":1771918700000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1733153\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,20]]},"references-count":31,"alternative-id":["10.3389\/fmed.2026.1733153"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1733153","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,20]]},"article-number":"1733153"}}